iBio (IBIO) Director Elizabeth Stoner Receives 60,000-Share Award

What Happened
Elizabeth Stoner, a director of iBio, received a grant/award of 60,000 shares (reported as a derivative acquisition) on 2026-05-18. The award is reported at $0.00 per share (no cash paid). This is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-18; filing date: 2026-05-19 (filed promptly).
• Transaction type/code: A — Grant, award or other acquisition (derivative).
• Shares granted: 60,000; reported price: $0.00 (no cash exchanged).
• Vesting: Footnote F1 — vests monthly on a pro rata basis over 36 months.
• Shares owned after transaction: Not specified in the provided filing.
• No tax withholding, sale, or 10b5-1 plan noted in the filing.

Context
This award appears to be a standard compensation/retention grant for a director and is subject to a 36‑month monthly vesting schedule, meaning shares will be delivered gradually. Such awards are common and reflect compensation practices rather than an immediate buy or sell signal; they do not necessarily indicate the insider’s personal market view.